Home Newsletters Intestinal Cell News RecQ-Like Helicase 4 (RECQL4) Exacerbates Resistance to Oxaliplatin in Colon Adenocarcinoma via...

RecQ-Like Helicase 4 (RECQL4) Exacerbates Resistance to Oxaliplatin in Colon Adenocarcinoma via Activation of the PI3K/AKT Signaling Pathway

By
Justin.choi
-
0
Researchers found RECQL4 was upregulated in colon adenocarcinoma (COAD), especially in Oxaliplatin-resistant COAD tissues and cells.
[Bioengineered]

Sorry, but the selected Zotpress account can't be found.

Full Article

RELATED ARTICLES

Exit mobile version